• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植受者外周血和支气管肺泡白细胞谱及其与免疫抑制方案变化的关系:单中心经验。

Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single-center experience.

机构信息

Department of Pulmonology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

Department of Genetics, Cell- and Immunobiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

出版信息

Immun Inflamm Dis. 2022 Aug;10(8):e673. doi: 10.1002/iid3.673.

DOI:10.1002/iid3.673
PMID:35894710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9274796/
Abstract

BACKGROUND

After lung transplantation (LuTX), lower respiratory tract infections (LRTI) and acute cellular rejection (ACR) are associated with changes in peripheral blood and bronchoalveolar lavage fluid mononuclear cell profile (PBMC and BALIC). PBMC is also influenced by immunosuppressive regimen and its changes with postoperative time. First-year PBMC and BALIC changes were evaluated in this study with rabbit anti-thymocyte globulin (ATG) and alemtuzumab (AL) induction therapy.

METHODS

In total, 64 LuTX recipients were included, 53 of them received AL and 11 ATG as induction therapy. PBMC and BALIC were examined routinely and in cases suspicious of infection and/or rejection. A PBMC- and BALIC-based algorithm for infection and rejection prediction was also tested.

RESULTS

In the AL group, peripheral blood lymphocyte and basophil cell numbers were significantly reduced, while the neutrophil cell number elevation during LRTI was significantly higher compared to the control. Early postoperative measurements showed a lower BALIC lymphocyte count. The algorithm had 17% sensitivity and 94% specificity for ACR in all patients and 33% sensitivity and 95% specificity for ACR with coexisting LRTI.

CONCLUSION

BALIC is not significantly influenced by the immunosuppressive regimen. PBMC- and BALIC-based algorithm may improve the differential diagnosis of ACR.

摘要

背景

肺移植(LuTX)后,下呼吸道感染(LRTI)和急性细胞排斥(ACR)与外周血和支气管肺泡灌洗液单核细胞谱(PBMC 和 BALIC)的变化相关。免疫抑制方案也会影响 PBMC,并且其随术后时间的变化而变化。本研究采用兔抗胸腺细胞球蛋白(ATG)和阿仑单抗(AL)诱导治疗,评估了第一年的 PBMC 和 BALIC 变化。

方法

共纳入 64 例 LuTX 受者,其中 53 例接受 AL,11 例接受 ATG 作为诱导治疗。常规检查 PBMC 和 BALIC,并在疑似感染和/或排斥时进行检查。还测试了基于 PBMC 和 BALIC 的感染和排斥预测算法。

结果

在 AL 组中,外周血淋巴细胞和嗜碱性粒细胞数量显著减少,而 LRTI 期间中性粒细胞数量升高更为明显。术后早期测量显示 BALIC 淋巴细胞计数较低。该算法在所有患者中对 ACR 的敏感性为 17%,特异性为 94%,对合并 LRTI 的 ACR 的敏感性为 33%,特异性为 95%。

结论

BALIC 不受免疫抑制方案的显著影响。基于 PBMC 和 BALIC 的算法可能有助于改善 ACR 的鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e42e/9274796/7248ff2b5ba4/IID3-10-e673-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e42e/9274796/a92015048ba8/IID3-10-e673-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e42e/9274796/7248ff2b5ba4/IID3-10-e673-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e42e/9274796/a92015048ba8/IID3-10-e673-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e42e/9274796/7248ff2b5ba4/IID3-10-e673-g002.jpg

相似文献

1
Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single-center experience.肺移植受者外周血和支气管肺泡白细胞谱及其与免疫抑制方案变化的关系:单中心经验。
Immun Inflamm Dis. 2022 Aug;10(8):e673. doi: 10.1002/iid3.673.
2
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
3
Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.阿仑单抗诱导治疗高度致敏的肾移植受者。
Chin Med J (Engl). 2011 Mar;124(5):664-8.
4
Induction immunosuppression strategies and outcomes post-lung transplant: A single center experience.肺移植后诱导免疫抑制策略和结果:单中心经验。
Transpl Immunol. 2024 Aug;85:102081. doi: 10.1016/j.trim.2024.102081. Epub 2024 Jul 8.
5
Antibody induction therapy for lung transplant recipients.肺移植受者的抗体诱导治疗。
Cochrane Database Syst Rev. 2013 Nov 27;2013(11):CD008927. doi: 10.1002/14651858.CD008927.pub2.
6
Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart--lung allograft recipients.肺和心肺移植受者在急性排斥反应和巨细胞病毒感染期间外周血、支气管肺泡灌洗液及经支气管活检标本的细胞学监测
Clin Transplant. 2001 Apr;15(2):77-88. doi: 10.1034/j.1399-0012.2001.150201.x.
7
Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.美国接受免疫抑制诱导的原发性儿科活体供肾移植受者的结局。
Pediatr Transplant. 2021 Aug;25(5):e13925. doi: 10.1111/petr.13925. Epub 2020 Dec 17.
8
Seasonal changes of lower respiratory tract infections in lung transplant recipients during the first post-transplant year: The Hungarian experience.肺移植受者术后第一年下呼吸道感染的季节性变化:匈牙利的经验
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12671. Epub 2017 Mar 11.
9
Alemtuzumab induction in renal transplantation.阿仑单抗诱导治疗肾移植。
N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546.
10
Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.比较他克莫司在接受和未接受巴利昔单抗治疗的肾移植受者中的细胞药代动力学。
Cell Transplant. 2012;21(2-3):565-70. doi: 10.3727/096368911X605493.

本文引用的文献

1
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study.诱导治疗对肺移植后外周血淋巴细胞的影响:一项多中心国际研究。
Transpl Immunol. 2018 Jun;48:47-54. doi: 10.1016/j.trim.2018.02.013. Epub 2018 Feb 21.
2
The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.支气管肺泡灌洗液 CXCL9 在微小急性排斥反应期间对慢性肺移植功能障碍风险的预后意义。
Am J Transplant. 2018 Jan;18(1):136-144. doi: 10.1111/ajt.14397. Epub 2017 Aug 2.
3
The immunological function of CD52 and its targeting in organ transplantation.
CD52的免疫功能及其在器官移植中的靶向作用。
Inflamm Res. 2017 Jul;66(7):571-578. doi: 10.1007/s00011-017-1032-8. Epub 2017 Mar 10.
4
Seasonal changes of lower respiratory tract infections in lung transplant recipients during the first post-transplant year: The Hungarian experience.肺移植受者术后第一年下呼吸道感染的季节性变化:匈牙利的经验
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12671. Epub 2017 Mar 11.
5
The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.国际心肺移植学会登记处:2016年第33份成人肺移植和心肺联合移植报告;重点主题:移植的主要诊断指征
J Heart Lung Transplant. 2016 Oct;35(10):1170-1184. doi: 10.1016/j.healun.2016.09.001. Epub 2016 Sep 13.
6
Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.血浆和支气管肺泡灌洗样本在急性肺移植排斥反应中的诊断价值:差异细胞学
Respir Res. 2016 Jun 21;17(1):74. doi: 10.1186/s12931-016-0391-y.
7
The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.阿仑单抗和巴利昔单抗诱导治疗对双肺移植受者生存及闭塞性细支气管炎综合征发生时间的影响
Am J Transplant. 2016 Aug;16(8):2334-41. doi: 10.1111/ajt.13739. Epub 2016 May 23.
8
Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study.阿仑单抗在肺移植中的应用:一项开放标签、随机、前瞻性单中心研究。
Am J Transplant. 2014 Aug;14(8):1839-45. doi: 10.1111/ajt.12824. Epub 2014 Jul 10.
9
Long-term outcomes following alemtuzumab induction in lung transplantation.阿仑单抗诱导治疗在肺移植中的长期疗效。
Heart Surg Forum. 2013 Oct;16(5):E252-6. doi: 10.1532/HSF98.2013160.
10
Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.人类外周血单核细胞表现出不均一的 CD52 表达水平,并对阿仑单抗介导的细胞溶解显示出不同的敏感性。
PLoS One. 2012;7(6):e39416. doi: 10.1371/journal.pone.0039416. Epub 2012 Jun 25.